ejpmr, 2019,6(4), 574-577 SJIF Impact Factor 4.

897
Research Article
Sujatha et al. EUROPEAN JOURNAL OF PHARMACEUTICAL
European Journal of Pharmaceutical and Medical Research
AND MEDICAL RESEARCH ISSN 2394-3211

www.ejpmr.com EJPMR

CURRENT SENERIO OF ANTIMICROBIAL RESISTANCE PATTERNS OF

PSEUDOMONAS AERUGINOSA CLINICAL ISOLATES IN EAST UTTAR PRADESH,
INDIA

Praveen Kumar Gautam1 and Dr. R. Sujatha2*

1
Department of Microbiology, Govt Medical College, Kannauj.
2
Department of Microbiology, Rama Medical College Hospital & Research Centre.

*Corresponding Author: Dr. R. Sujatha

Department of Microbiology, Rama Medical College Hospital & Research Centre.

Article Received on 13/02/2019 Article Revised on 06/03/2019 Article Accepted on 27/03/2019

ABSTRACT
Background: Pseudomonas aeruginosa is an important pathogen isolated among non- fermenter gram negative
bacilli from various clinical specimens. Increasing resistance had documented among P. aeruginosa stains to
commonly used antimicrobial agents. This study aimed to investigate the anitimicrobial resistance patterns of
Pseudomonas aeruginosa from various clinical samples. Methods: From June 2018 to December 2018 a total 39
strains of Pseudomonas aeruginosa were isolated from various clinical specimens and characterized by standard
bacteriological procedures. Antimicrobial susceptibility patterns of each isolates were carried out by the Kieby-
Bauer disk diffusion method as per CLSI guidelines. Result: The maximum Pseudomonas aeruginosa ware
susceptibility to Meropenum and levofloxacin (66.67%) while maximum resistance was found to cephalosporins
(100%). Conclusion: The results of this study confirmed the occurrence of drugs resistance strains of
Pseudomonas aeruginosa. So there is a continuous need of conduction of surveillance programmers to formulate
rational treatment strategies to combat this emerging challenge.

KEYWORDS: Pseudomonas Aeruginosa, Resistance, Antibiotic susceptibility.

INTRODUCTION difficulty to treat infection caused by Pseudomonas

The genus Pseudomonas aeruginosa comprises of more aeruginosa.[6-7]
than 140 species, Pseudomonas aeruginosa is one of the
common bacterial pathogen isolated from various Because of the facts, studies on current antimicrobial
clinical samples. The others are essentially saprophytic resistance pattern of Pseudomonas are essential to find
and occur widely in nature. It range causes a wide range out the susceptibly of this pathogen against commonly
of infections including bacteraemia, pneumonia, prescribed antibiotics in any health care facility. This
meningitis, urinary tract and wound infections. [1-2] will help to the clinician to optimize the current senerio
of treatment.
Infections due to Pseudomonas aeruginosa are also seen
in healthy individuals but last two decades the organism MATERIAL AND METHODS
has become increasingly recognized as the etiological This study was conducted at Government Medical
agent in a variety of serious infections in hospitalized College. Total 100 clinical samples like Ear pus/ Pus,
patients with impaired immune defense including HIV urine, Endo- tracheal tube, Sputum and Foley’s tip were
infections.[3] collected from patients admitted in wards.

Antimicrobial agents have been the only easily and Inclusion Criteria for patients
widely used therapeutic option available to counter the Patients admitted to different departments of the hospital
infections caused by various microbial agents. The included in this study.
development of resistance to all available antibiotics in
some organisms may preclude the effectiveness of any Exclusion Criteria for Patients
antibiotic regimen.[4-5] Patients coming as outpatient to emergency were not
included
Pseudomonas aeruginosa exhibits intrinsically high
resistance too many antimicrobials and the development Sample processing
of increased multidrug resistance in health care setup is a The collected samples were subjected to direct Gram
stain and all specimens were inoculated onto nutrient

www.ejpmr.com 574
Sujatha et al. European Journal of Pharmaceutical and Medical Research

agar, 5% sheep blood agar and MacConkey’s agar Table. 2: Distribution of specimens of Pseudomonas
medium. Urine samples were inoculated onto Cystine aeruginosa clinical isolates.
Lactose Electrolyte Deficient agar (CLED). Total No. of Total no of
Type of samples Samples Isolates
All the catalase positive, oxidase positive, non-lactose (n=100) (n=39)
fermenting colonies on Mac Conkey agar were Ear Pus/ Pus 40 20
provisionally identified by colony morphology and Urine 36 12
pigment production. They were inoculated in Triple Endo-Tracheal tube 17 05
sugar iron (TSI) agar slope. The colonies which failed to Sputum 05 01
acidify the TSI agar were considered as non-fermenters Foley’s tip 02 01
and subjected to Hugh – leifson oxidation – fermentation Total 100 39
and Decarboxylation of Lysine, Arginine and Ornithine
test.Cetramide agar medium has been used as it is Antimicrobial susceptibility patterns of Pseudomonas
selective for pseudomonas. varied markedly with the antibiotics tested. P. aeruginisa
showed maximum resistance to cephalosporins (100%),
Antibiotic susceptibility Testing: AST were done by Minimum resistances to Meropenum and Levofloxacin
Kirby Bauer Method using various antibiotic discs 33.34% for both. The sensitivity pattern of the P.
(HIMEDIA) including Meropenem (MRP), Imipenem aeruginosa to various antibiotics tested was in order to
(IPM), Amikacin (AK), Gemtamicin (GEN), Meropenum and Levofloxacin (66.67%) >Imipenum
Ciprofloxacin (CIP), Levofloxacin (LE), Ppiperacillin- (58.97%) >Piperacillin- tazobactam (56.41%)
tazobactam (PIT), Cefotaxime (CTX), Cefepime (CPM). >Amikacin and Gentamycin (51.28%) > Ciprofloxacin
(41%) as shown in Table 3.
RESULT
In present study 39 strains of Pseudomonas aeruginosa Table. 3: Antimicrobial susceptibility patterns of
were isolated and identified by standard microbiological Pseudomonas aeruginosa clinical isolates.
procedures, out of total of 100 clinical specimens Sensitivity no. Resistance no.
investigated. The rate of isolation of P. aeruginosawas Antibiotics
(%) (%)
39% of theses 39 strains of P. aeruginosa, 21 (53.8%)
Carbepenems
were from females and 18 (46.15%) were from males.
Meropenum 26 (66.67%) 13 (33.34%)
Most of them belonged to the age group 21-40 years (19,
Imipenum 23 (58.97%) 16 (41.0%)
48.7%) followed by patient of 41-60 years of age (13,
33.34%) as shows in table 1. Ear pus/ pus, urine, Endo- Aminoglycosides
tracheal tube (93, 93%) were the predominant sources of Amikacin 20 (51.28%) 19 (48.71%)
specimens of Pseudomonas aeruginosa clinical isolates Gentamycin 20 (51.28%) 19 (48.71%)
as depicted in table 2. Fluroquinolones
Levofloxacin 26 (66.67%) 13 (33.34%)
Table. 1: Age and gender wise distribution of clinical Ciprofloxacin 16 (41.0%) 23 (58.97%)
isolates of Pseudomonas aeruginosa. Ureidopenicillin
Male Female Total No. Piperacillin-
Age (Years) 22 (56.41%) 17 (43.58%)
(No.) (No.) (%) tazobactam
04 Cephalosporins
<20 01 03 Cefotaxime 0 (0%) 39 (100%)
(10.25%)
19 Cefepime 0 (0%) 39 (100%)
21-40 10 09
(41.02%)
13 DISCUSSION
41-60 08 05 Increasing of resistance by Pseudomonas aeuroginosa
(33.34%)
03 has now become a major threat in medical world.
>60 02 01
(7.69%)
2 18 In this study, we assessed the increasing incidence of
Total 39 (100%) resistance in patients of various departments in a tertiary
(53.81%) (46.15%)
care hospital. In our study the most number of P.
aeruginosa isolated was from pus sample n=20 followed
by urine n=12, endo-tracheal tube n=05, sputum n=01
and Folye’s tip n=01. The isolation rate from different
clinical samples varies according to the condition and the
specimen. These results are in line with previous
studies.[8,9,10,11] The isolation rate from different clinical
isolates varies according to the condition and specimen.

www.ejpmr.com 575
Sujatha et al. European Journal of Pharmaceutical and Medical Research

A high rate of P. aeruginosa has been isolated from the treatment. Treatment should be on the basis of anti-
age group 12-40 years in present study. These finding microbial susceptibility testing is essential.
supported by previous study [10]. This may be due to
maximum occupational exposure to the organism. REFERENCES
1. PrakashV, Mishra PP, Premi HK, Walia A, Dhawan
In present study we found the more prevalence in male S, Kumar A. Increasing incidence of multidrug
(53.81%) than female (46.15%). A previous study from resistant Pseudomonas aeruginosa in patients of
Nigeria and other from Bareilly (Uttar Pradesh) also tertiary care hospital. Int J Res Med Sci., 2014; 2:
reported high prevalence rate in male than female [1, 12]. 1302-6
2. Adedeji G.B, Fahade O.E, and Oyelade A.A,
Increasing resistance to different anti- pseudomonal Prevalence of Pseudomonas aeruginosa in clinical
drugs particularly among hospital strains has been samples and its sensitivity to citrus extract. African
reported worldwide [13, 14] and this is serious therapeutic Journal of Biomedical Research, 2007; 10: 183-187.
problem in the management of disease due to these 3. Jamshaid Alikhan et al. Prevalence and resistance
organisms. The resistance profile of P. aeruginosa to the pattern of Pseudomonas against various antibiotics.
ten anti- microbial agents tested varied among the Pak. J. Pharma.Sci. July 2008; 21(3): 311-15.
isolated investigated. One striking feature in present 4. Carmeli Y, Troillett N, Karchmer AW, Samore MH.
study was that maximum P. aeruginosa isolates were Health and economic outcomes of antibiotic
found to be sensitive to meropenum (MRP) and resistance in Pseudomonas aeruginosa. Arch Intern
levofloxacin (Le). This may be due to the limited use to Med., 1999; 159: 1127-32.
these antibiotics at this hospital. 5. Acar JF. Conequences of bacterial resistance to
antibiotics in medical practice. Clin Infect Dis 1997;
Imipenum resistance rate was 41% in present study. 24(suppl1): 517-518.
Other study from various place support our findings of 6. Poole K. Pseudomonas aeruginosa: resistance to the
resistance to Imipenum in recent years [10, 11, 15, 16]. max. front microbiology, 2011; 2: 1-13.
Aminoglycosides resistance rate found to be 48.71% in 7. Kerr KG, Snelling AM. Pseudomonas aeruginosa: a
present study. A high resistance rate to aminoglycosides formidable and ever-present adverrary. J Hosp Infect
has been reportes in studies done in India [10, 11], 2009; 73: 338-44
Bangladesh [17], Turkey [18] and from Malaysia [19]. 8. Javiya VA, Ghatak SB, Patel JA. Antibiotic
suscepiblity patterns of Paseudomonas aeruginosa at
Ciprofloxacin and Levofloxacin shows resistance rate tertiary care hospital in Gujarat. Indian J pharmacol,
58.97% and 33.34% respectively. A 3 year study from 208; 40(5): 230-4.
India also reported ciprofloxacin resistance of 63.1% [12] 9. Chaudhari VL, Gunjal SS, Mehta M. Antibiotic
Two other study from India [20, 21] and Bangladesh [22] resistance patterns of Pseudomonas aeruginosa in a
also reported similar resistance to ciprofloxacin. tertiary care hospital in central India. Int J Med Sci
public Health, 2013; 2: 386-9.
The ureidopenicillin group represented by Piperacillin- 10. . Mohanasoundaram KM. The antibiotic resistance
tazobactam showed a relatively lower resistance of pattern in the clinical isolates of Pseudomonas
43.58%. A study from Bareilly [14] and from India [20] aeruginosa in a tertiary care hospital: 2008-2010 (A
reported resistance to piperacillin-tazobactam was 3 year study). J. clin Diagn Res., 2011; 5(3): 491-94.
32.33% and 45.6% respectively. 11. Arora D, Jindal N Kumar R, Romit. Emerging
antibiotic resistance in Preudomonas aeruginosa. Int
The resistance rate of 3rd generation cephalosporins J pharma sci., 2011; 3(2): 82-4.
shows 100% resistance to P.aeruginosa in present study. 12. O KO, APC, OW, BST, UA. Antibiotic resistance
Remarkable resistance to 3rd generation cephalosporins pattern of Pseudomonas aeruginosa isolated from
were also recorded (>90%) by Bhale Rao et al and (96- clinical specimens in a tertiary hospital in north
100%) by Awari et al in India [23, 24]. This indicate the eastern Nigeria. The internet journal of
increasing resistance of drugs in current senerio which microbiology, 2009; 8(2): 1-5.
can be due to blind therapy, due to acquire resistance of 13. Orrett FA. Antimicrobial susceptibility survey of
P. aeruginosa, low permeablity and production of Pseudimonas aeruginosa a strains isolated from
inducible cephalosporins, lack of awereness for clinical sources. J natl med Assoc, 2004; 96(8):
antibiotics. 1065-69.
14. Chen HY, Yuan M, Livermore DM. Mechanisms of
CONCLUSION resistance to beta- lactam antibiotics amongst
Findings of antibiotic sensitivity testing clearly Pseudomonas aeruginosa isolates collected in the
demonstrate the occurrence of resistance to various anti United Kingdom in 1993. J med microbial, 1995;
microbial agents among the Pseudomonas aeruginosa 43: 300-09.
isolates. Meropenum and Levofloxacin were two most 15. Al- kabsi AM, Yusof MYBM, Sekaran SD.
sensitive drugs against P. aeruginosa. We suggest for Antimicrobial resistance pattern of clinical isolates
judicious strategy on the restricted use of these drugs for of Pseudomonas aeruginosa in the university of

www.ejpmr.com 576
Sujatha et al. European Journal of Pharmaceutical and Medical Research

Malaya Medical Center Malaysia, Afr. J Miceobiol

Res., 2011; 5(29): 5266-72.
16. Shigeki Fujitani and Victor L, Yu. Diagnosis of
Ventilator-Associated Pneumonia: Focus on Non-
bronchoscopic Techniques and Blinded Bronchial
Sampling and Endotracheal Aspirates Non-
bronchoscopi Bronchoalveolar Lavage, Including
Mini-BAL, Blinded Protected Specimen Brush J
Intensive Care Med., 2006; 21; 17.
17. Rashid, Chowdhur A, Rahman SHZ, Begum SA,
Muazzam N. Infections by Pseudomonas aeruginosa
and antibiotic resistance pattern of the isolates from
Dhaka medical college, hospital. Banglsdes J med
microbial, 2007; 1(2): 48-51.
18. Savas L, Duran N, Savas N, Onlen Y, Ocakas. The
prevalence and resistance patterns of Pseudomonas
aeruginosa in intensive care unit in a University
hospital. Turk J Med Sci., 2005; 35: 317-22.
19. Fazlul MKK, Zaini MZ, Rashid MA, Naznul MHM.
Antibiotic susceptibility profile of clinical isolates of
Pseudomonas aeruginisa from Selayang hospital
Malaysia. Biomed Res., 2011; 22(3): 263-66.
20. Angadi KM, Kadam M, Modakh MS et al.
Detection of Antibiotic resistance in Pseudomonas
aeruginosa isolates with special reference to metallo
β- lactamases from a tertiary care Hospital in
Western India. International Journal of
Microbiology Research, 2012; 14(7): 295-8
21. Meenakumari S, Verma S, Absar A et al.
Anti.microbial susceptibility pattern of clinical
isolates of Pseudomonas aeruginosa in an Indian
cardiac Hopital. International Journal of Engireering
Science and Technology, 2011; 3: 7117-23.
22. Hoque MM, Ahmad M, Khusa S, Uddin MN and
Jesmine R. Antibiotic resistance patterns in
Pseudomonas aeruginosa isolated from different
clinical specimens. JAFMC Bangladesh, Vol11, No.
1 (June) 2015.
23. Bhale rao D, Roushni S, Kinikar AG. Study of
metallo- beta lactamase Pseudomonas aeruginosa in
Pravara rural Hospital. Pravara Medical Review,
2010; 5(3): 16-9.
24. Awari A and Nighute S. Incidence of Metallo-beta
lactamase producing Pseudomonas aeruginosa in
Kesar SAL Medical College and Hospital,
Ahmedabad. International journal of Biomedical
Research, 2012; 3(11): 32-5.

www.ejpmr.com 577